BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27783367)

  • 1. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m
    Chong K; Ikramuddin S; Lee WJ; Billington CJ; Bantle JP; Wang Q; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Korner J; Chuang LM
    Obes Surg; 2017 May; 27(5):1189-1195. PubMed ID: 27783367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
    Ikramuddin S; Korner J; Lee WJ; Connett JE; Inabnet WB; Billington CJ; Thomas AJ; Leslie DB; Chong K; Jeffery RW; Ahmed L; Vella A; Chuang LM; Bessler M; Sarr MG; Swain JM; Laqua P; Jensen MD; Bantle JP
    JAMA; 2013 Jun; 309(21):2240-9. PubMed ID: 23736733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
    Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.
    Courcoulas AP; Belle SH; Neiberg RH; Pierson SK; Eagleton JK; Kalarchian MA; DeLany JP; Lang W; Jakicic JM
    JAMA Surg; 2015 Oct; 150(10):931-40. PubMed ID: 26132586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
    Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
    Feng W; Yin T; Chu X; Shan X; Jiang C; Wang Y; Qian Y; Zhu D; Sun X; Bi Y
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3138. PubMed ID: 30740871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.
    Madsen LR; Baggesen LM; Richelsen B; Thomsen RW
    Diabetologia; 2019 Apr; 62(4):611-620. PubMed ID: 30734055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect and Predictive Score of Gastric Bypass and Sleeve Gastrectomy on Type 2 Diabetes Mellitus Patients with BMI < 30 kg/m(2).
    Lee WJ; Almulaifi A; Chong K; Chen SC; Tsou JJ; Ser KH; Lee YC; Chen JC
    Obes Surg; 2015 Oct; 25(10):1772-8. PubMed ID: 25676157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2.
    Yu H; Di J; Bao Y; Zhang P; Zhang L; Tu Y; Han X; Jia W
    Surg Obes Relat Dis; 2015; 11(1):6-11. PubMed ID: 25547054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.
    Cummings DE; Arterburn DE; Westbrook EO; Kuzma JN; Stewart SD; Chan CP; Bock SN; Landers JT; Kratz M; Foster-Schubert KE; Flum DR
    Diabetologia; 2016 May; 59(5):945-53. PubMed ID: 26983924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus.
    Lakdawala M; Shaikh S; Bandukwala S; Remedios C; Shah M; Bhasker AG
    Surg Obes Relat Dis; 2013; 9(3):370-8. PubMed ID: 23068107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.
    Simonson DC; Halperin F; Foster K; Vernon A; Goldfine AB
    Diabetes Care; 2018 Apr; 41(4):670-679. PubMed ID: 29432125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m
    Cheng A; Yeoh E; Moh A; Low S; Tan CH; Lam B; Sum CF; Subramaniam T; Lim SC
    Diabetes Res Clin Pract; 2022 Jun; 188():109900. PubMed ID: 35513159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.
    Huang CK; Tai CM; Chang PC; Malapan K; Tsai CC; Yolsuriyanwong K
    Obes Surg; 2016 Oct; 26(10):2291-301. PubMed ID: 26935711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m
    Ke Z; Li F; Chen J; Gao Y; Zhou X; Sun F; Li C; Liu B; Li Q; Zhu Z; Tong W
    Obes Surg; 2017 Nov; 27(11):3040-3047. PubMed ID: 28905292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
    Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.
    Park JY; Kim YJ
    Obes Surg; 2016 Apr; 26(4):749-56. PubMed ID: 26205218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of short-term diabetes remission after laparoscopic Roux-en-Y gastric bypass.
    Iacobellis G; Xu C; Campo RE; De La Cruz-Munoz NF
    Obes Surg; 2015 May; 25(5):782-7. PubMed ID: 25361763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis.
    Cohen R; Le Roux CW; Junqueira S; Ribeiro RA; Luque A
    Obes Surg; 2017 Oct; 27(10):2733-2739. PubMed ID: 28785975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.